RE: DHSC debacle19 Sep 2021 13:32
Covid, I am well aware of Porky's infamous £54 share price prediction. Will it ever get there? Why not but I certainly don't expect it within the next 3 years. £18 if all the stars align being
favourable dispute resolution.
Self test LFT sales growth,
US expansion (who knows what this looks like but I can be sure that close to zero is priced into the current SP)
Next gen antibody test (not sure about this tbh)
M&A (anything can happen here)
LFT Antigen Pro sales growth (highly competitive market but if we do it right and get our foot in then this could be highly lucrative)
Variant checking (I suspect lower volume sales, higher margin but greater product life cycle)
Further contracts with DHSC. What is to say we don't sort out this dispute, build our relationship again with the £4.7m contract which then unlocks the door to multiple much larger contracts.
All this could happen and depending on when £18 would be more than achievable but probably looking at around 12 months.
Who knows.
Having said all of that, many things can go unexpectedly wrong as we know. That is the risk which is currently why the SP is £3.10. We has investors have to evaluate the fundamentals, sentiment, future and decide. Is Ncyt going to be worth more in the future than it is today? I certainly believe it will.
Don't know anything about VAL so won't comment.